Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04363801
Title A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer (DisTinGuish)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Leap Therapeutics, Inc.
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

DKN-01 + Tislelizumab

Capecitabine + DKN-01 + Oxaliplatin + Tislelizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.